These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 210899)

  • 21. [Experimental studies on thrombolytic agents. (1) Comparison between prostaglandin E1, heparin and urokinase (author's transl)].
    Suzuki T; Takano S
    Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):890-6. PubMed ID: 735704
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of controlled release of prostaglandin from polymer matrices for thrombus prevention.
    McRea JC; Kim SW
    Trans Am Soc Artif Intern Organs; 1978; 24():746-52. PubMed ID: 362677
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of some pyrimido-pyrimidine derivatives on blood coagulation and platelet aggregation.
    Bédi J; Blaskó G; Pálos LA
    Arzneimittelforschung; 1979; 29(9):1405-8. PubMed ID: 583250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the role of cyclic 3',5'-adenosine monophosphate in platelet functions with special reference to aggregation and serotonin release of human blood platelets.
    Ryo R
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):85-96. PubMed ID: 183445
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of calcium-induced reptilase clot retraction.
    Kubisz P; Suranová J; Cronberg S
    Scand J Haematol; 1976 Apr; 16(4):263-5. PubMed ID: 935809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Platelet suppressive drugs (author's transl)].
    Shio H; Kameyama M
    No Shinkei Geka; 1981 Feb; 9(2):113-22. PubMed ID: 6264335
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biochemical mechanisms in inducing of coagulation by collagen (author's transl)].
    Wuppermann T; Hörmann H
    Klin Wochenschr; 1974 May; 52(9):409-18. PubMed ID: 4369497
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of Soviet-made prostaglandin E1 on the aggregation of thrombocytes and erythrocytes].
    Lakin KM; Makarov VA; Ovnatanova MS; Azhgikhin IS
    Farmakol Toksikol; 1976; 39(4):436-40. PubMed ID: 1027569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 3. Significance of prostaglandins and cAMP for aggregation inhibiting effect and other effects of sulfonylurea compounds].
    Scholz VC; Hoder A; Losert W
    Arzneimittelforschung; 1975 Mar; 25(3):347-61. PubMed ID: 239727
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW; Levine L
    J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
    Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of cyclic adenosine 3,5-monophosphate and prostaglandin E2 in the mechanism of the inhibitory action of nicotinic acid on thrombocyte aggregation].
    Sushkevich GN; Chebotarevskaia LV; Siatkovskiĭ VA
    Biull Eksp Biol Med; 1982 Apr; 93(4):17-9. PubMed ID: 6282359
    [No Abstract]   [Full Text] [Related]  

  • 35. [Coagulation factors and thrombocytes after application of Reptilase in the course of gynecologic operations (author's transl)].
    Cornely M; Barthels M; Henkel E
    Med Klin; 1978 May; 73(20):760-4. PubMed ID: 651762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E1: the endogenous physiological regulator of platelet mediated blood coagulation.
    Dutta-Roy AK; Kahn NN; Sinha AK
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(4):189-95. PubMed ID: 2541451
    [No Abstract]   [Full Text] [Related]  

  • 37. [Platelet glucose metabolism and its function--energy dependency of fresh- and fixed-platelets in aggregation and clot retraction-- (author's transl)].
    Taketomi Y; Kuramoto A
    Nihon Ketsueki Gakkai Zasshi; 1976 Oct; 39(5):671-81. PubMed ID: 1037349
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence that electrical and mechanical stimulation can induce reptilase-clot retraction.
    Fantin GP; Bottecchia D; Nassuato G; Gruppo Zatti P
    Thromb Res; 1976 Apr; 8(4):523-8. PubMed ID: 1273812
    [No Abstract]   [Full Text] [Related]  

  • 39. Human platelet aggregation tests in vitro. Effects of dilazep.
    Ponari O; Manotti C
    Arzneimittelforschung; 1981; 31(1):97-101. PubMed ID: 7194099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of ADP-induced reptilase clot retraction by specific antibodies.
    Kubisz P; Cronberg S; Caen JP
    Thromb Haemost; 1978 Feb; 39(1):236-7. PubMed ID: 580499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.